why did i stop losing weight on tirzepatide Not tirzepatide? Here's what to do about it πSt. Louis Weight Loss |
Description
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
Ready to discover whether Semaglutide or Tirzepatide is right for you

Knock it off

per bottle

However, losing weight is only half the battle
In a multicenter, double-blind, randomized, placebo-controlled, event-driven superiority trial, designed to evaluate the efficacy and safety of 2.4 mg semaglutide in patients 45 years old with preexisting cardiovascular disease and a BMI 27 kg/m 2 but no history of diabetes, the trial randomly assigned 17,604 patients to receive semaglutide or placebo to determine whether semaglutide is superior to placebo in reducing cardiovascular events
